Search results
Results from the WOW.Com Content Network
A new study says that type 2 diabetes medications GLP-1 agonists and SGLT2 inhibitors may help lower a stroke survivor’s risk of experiencing a subsequent stroke, heart attack, or death ...
Heart disease, which includes heart attack and stroke, is the leading cause of death in the U.S., according to the Centers for Disease Control and Prevention (CDC).
People who were diagnosed with severe COVID-19 infections from the first wave of the pandemic could face double the risk of heart attack and stroke, a new study has found. Researchers focused on ...
COVID-19 and heart attack, stroke risk The team of American researchers used data from the UK Biobank , a leading source for health data. The study included 219,673 people, 10,005 of whom had a ...
The trial included more than 17,600 adults ages 45 and up with heart disease who got either a weekly 2.4-milligram dose of semaglutide, which is the drug used in Wegovy, or a placebo. About three ...
The Cambridge team and scientists at Fudan University, China, examined the "proteomes," or the suite of proteins, in blood samples donated by more than 42,000 British adults aged 40 to 69.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Three blood biomarkers could help predict heart attack and stroke risk in women. Image credit: Angela Lumsden/ Stocksy . Cardiovascular disease is the leading cause of death in women globally.